LZTR1 functions as a two-hit tumor suppressor in childhood acute lymphoblastic leukemia
Adeline Bonnard(Université Paris Cité), Hélène Cavé(Hôpital Robert-Debré), Beat Bornhäuser(University Children's Hospital Zurich), Jean‐Hugues Dalle(Inserm), Cécile Pochon(Université de Lorraine), Marion Strullu(Hôpital Robert-Debré), Fabio D. Steffen(University Children's Hospital Zurich), Damien Bodet, Chloé Arfeuille, Arnaud Petit(Sorbonne Université), Séverine Drunat(Délégation Paris 7), Nastassja K. Scheidegger(University of Zurich), Claire Freyçon(Montreal Children's Hospital), Pauline Simon(Centre Hospitalier Universitaire de Besançon), Yoann Vial(Délégation Paris 5), Aurélie Caye‐Eude(Inserm), André Baruchel(Hôpital Robert-Debré), Catherine Paillard(Sorbonne Université), Anna Dehler(University Children's Hospital Zurich), Élodie Lainey(Inserm)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)
|Blood|2005|376